Diabetic Muscle Infarction : Resolution of Rare Microangiopathy with Over-The-Counter Medication
Copyright © 2021 Roopam Jariwal et al..
Diabetic muscle infarction (DMI) is a rare complication of poorly controlled type 1 and type 2 diabetes seen mostly in those who have already experienced microvascular complications. Currently, the incidence and prevalence of DMI are difficult to conclude, and there is no clear algorithm or standard of care in managing this condition. Pathogenesis of the microangiopathy of DMI remains unclear. A major finding in this investigation of DMI emphasizes that, within 2-17 weeks, patients who initiate low-dose acetylsalicylic acid, bed rest, and close outpatient follow-up see significant size reduction of lower extremity mass and complete resolution of pain without being subjected to invasive muscle biopsy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2021 |
|---|---|
| Enthalten in: |
Case reports in medicine - 2021(2021) vom: 09., Seite 5555051 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jariwal, Roopam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 03.08.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1155/2021/5555051 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328803308 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328803308 | ||
| 003 | DE-627 | ||
| 005 | 20231225203725.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1155/2021/5555051 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1095.xml |
| 035 | |a (DE-627)NLM328803308 | ||
| 035 | |a (NLM)34335786 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jariwal, Roopam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diabetic Muscle Infarction |b Resolution of Rare Microangiopathy with Over-The-Counter Medication |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 03.08.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021 Roopam Jariwal et al. | ||
| 520 | |a Diabetic muscle infarction (DMI) is a rare complication of poorly controlled type 1 and type 2 diabetes seen mostly in those who have already experienced microvascular complications. Currently, the incidence and prevalence of DMI are difficult to conclude, and there is no clear algorithm or standard of care in managing this condition. Pathogenesis of the microangiopathy of DMI remains unclear. A major finding in this investigation of DMI emphasizes that, within 2-17 weeks, patients who initiate low-dose acetylsalicylic acid, bed rest, and close outpatient follow-up see significant size reduction of lower extremity mass and complete resolution of pain without being subjected to invasive muscle biopsy | ||
| 650 | 4 | |a Case Reports | |
| 700 | 1 | |a Raza, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Cadang, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Rahman, Syed |e verfasserin |4 aut | |
| 700 | 1 | |a Contreras, David |e verfasserin |4 aut | |
| 700 | 1 | |a Sidhu, Ramanjeet |e verfasserin |4 aut | |
| 700 | 1 | |a Bhandohal, Janpreet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Case reports in medicine |d 2009 |g 2021(2021) vom: 09., Seite 5555051 |w (DE-627)NLM190923628 |x 1687-9627 |7 nnns |
| 773 | 1 | 8 | |g volume:2021 |g year:2021 |g day:09 |g pages:5555051 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1155/2021/5555051 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2021 |j 2021 |b 09 |h 5555051 | ||